![Stephen B. H. Kent](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stephen B. H. Kent
Corporate Officer/Principal chez
The University of Chicago
Profil
Stephen B. H.
Kent was the founder of Gryphon Therapeutics, Inc. (founded in 1994) where he held the title of Chief Scientific Officer from 1994 to 2002.
Dr. Kent is also the founder of Opal Therapeutics Pty Ltd. Dr. Kent's current jobs include being the Director-Institute Biophysical Dynamics at The University of Chicago since 2001 and the Director-Center Functional Genomics at Victoria University of Wellington since 2004.
Dr. Kent's former jobs include being the Lead Independent Director at Enzo Biochem, Inc. in 2012 and being a Director at Ciphergen Biosystems KK from 1994 to 1997.
Dr. Kent obtained his doctorate degree from the University of California, Berkeley.
Postes actifs de Stephen B. H. Kent
| Sociétés | Poste | Début |
|---|---|---|
The University of Chicago
 The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/2001 |
Victoria University of Wellington
 Victoria University of Wellington Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/2004 |
Anciens postes connus de Stephen B. H. Kent
| Sociétés | Poste | Fin |
|---|---|---|
Gryphon Therapeutics, Inc.
 Gryphon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and produces protein therapeutics | Fondateur | 01/01/2002 |
Ciphergen Biosystems KK
 Ciphergen Biosystems KK Electronic Equipment/InstrumentsElectronic Technology Markets & supplies proteinchip systems and services | Directeur/Membre du Conseil | 01/01/1997 |
Opal Therapeutics Pty Ltd.
 Opal Therapeutics Pty Ltd. Pharmaceuticals: MajorHealth Technology Develops immunotherapy for HIV and Hepatitis C & chronic infection | Fondateur | - |
| ENZO BIOCHEM, INC. | Directeur/Membre du Conseil | - |
Formation de Stephen B. H. Kent
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
97
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Enzo Biochem, Inc.
 Enzo Biochem, Inc. BiotechnologyHealth Technology Provides enabling life science technologies for research, drug discovery, drug development and diagnostic solutions | Health Technology |
Gryphon Therapeutics, Inc.
Gryphon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and produces protein therapeutics | Health Technology |
Ciphergen Biosystems KK
Ciphergen Biosystems KK Electronic Equipment/InstrumentsElectronic Technology Markets & supplies proteinchip systems and services | Electronic Technology |
The University of Chicago
The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Victoria University of Wellington
Victoria University of Wellington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Opal Therapeutics Pty Ltd.
Opal Therapeutics Pty Ltd. Pharmaceuticals: MajorHealth Technology Develops immunotherapy for HIV and Hepatitis C & chronic infection | Health Technology |
